-Castle Biosciences, Inc. - Recommendations by Expert Consensus Panel Relating to Risk-Stratification Tests and Tools for Use in Cutaneous Melanoma Have Been Adopted as an Official Policy Recommendation of the National Society for Cutaneous Medicine

  • Matthew Goldberg

Press/Media

Period9 Mar 2023

Media coverage

2

Media coverage

  • Title-Castle Biosciences, Inc. - Recommendations by Expert Consensus Panel Relating to Risk-Stratification Tests and Tools for Use in Cutaneous Melanoma Have Been Adopted as an Official Policy Recommendation of the National Society for Cutaneous Medicine
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date9/03/23
    PersonsMatthew Goldberg
  • Title-Castle Biosciences, Inc. - Recommendations by Expert Consensus Panel Relating to Risk-Stratification Tests and Tools for Use in Cutaneous Melanoma Have Been Adopted as an Official Policy Recommendation of the National Society for Cutaneous Medicine
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date9/03/23
    PersonsMatthew Goldberg